We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

ThermoGenesis Holdings Inc (THMO) USD0.001

Sell:$0.36 Buy:$0.39 Change: $0.0048 (1.26%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$0.36
Buy:$0.39
Change: $0.0048 (1.26%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$0.36
Buy:$0.39
Change: $0.0048 (1.26%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

ThermoGenesis Holdings, Inc. develops, commercializes and markets a range of automated technologies for chimeric antigen receptor- T (CAR-T) and other cell-based therapies. The Company provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and CAR-TXpress platform for large scale cell manufacturing services. It manufactures and markets three categories of products, Clinical Bio-Banking Applications, Point-of-Care Applications, and Large Scale Cell Processing and Biomanufacturing. Its Clinical Bio-Banking Applications includes AXP II Automated Cell Separation System and BioArchive Automated Cryopreservation System. Point-of-Care Applications includes PXP Point-of-Care System, PXP-LAVARE System and PXP-1000 System. Its Large Scale Cell Processing and Biomanufacturing includes X-Series Products for general laboratory useand CAR-TXpress Platform for clinical manufacturing.

Contact details

Address:
2711 Citrus Rd
RANCHO CORDOVA
95742-6228
United States
Telephone:
+1 (916) 8585100
Website:
https://thermogenesis.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
THMO
ISIN:
US88362L1008
Market cap:
$4.98 million
Shares in issue:
12.83 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Xiaochun Xu
    Chairman of the Board, President, Chief Executive Officer
  • Jeffery Cauble
    Chief Financial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.